简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2018-02-13 16:00 New Study Evaluates the Performance of Masimo PVi® as a Predictor of Fluid Responsiveness in Mechanically Ventilated ICU Patients
2018-02-09 13:56 6th Annual World Patient Safety, Science & Technology Summit Is SOLD OUT!
2018-02-08 17:27 Gluco-Chaser&trade Inc. Announces Disposable Strip Glucose Sensor Results
2018-02-08 11:36 Masimo Announces CE Marking of Eve™ CCHD Newborn Screening Application for the Rad-97™ Pulse CO-Oximeter®
2018-02-06 12:06 “‘Someday’ is Now!”: Anpac Bio & Med Partners Celebrate ‘National Cancer Prevention Month’ Surpassing 60,000 ‘Liquid Biopsy’ Cases
2018-02-05 12:02 PharmAbcine Enters Collaboration with MSD Focused on Clinical Evaluation of TTAC-0001 in Combination with KEYTRUDA® (pembrolizumab) in Recurrent Glioblastoma and Breast Cancer
2018-02-05 10:05 Self Confidence Surges: Look Good Feel Better Global Survey Shows Significant, Positive Impact among Women in Cancer Treatment
2018-02-02 18:38 World Health Organization Director-General to Deliver Keynote at Patient Safety Summit
2018-02-02 16:10 Takeda Reports 3rd Quarter FY2017 Results
2018-01-31 18:08 MJC I-Ching Research Centre - Bringing Good Fortune, Harmony and Prosperity to Real Estate Developments
2018-01-31 14:58 Takeda’s Zika Vaccine Candidate Receives U.S. FDA Fast Track Designation
2018-01-30 10:08 PMI Presents to US FDA Advisory Committee; Important Milestone in the Scientific Review of IQOS
2018-01-26 14:24 Ferring Announces Recipients of Innovation Grants Program 2017-2018
2018-01-25 11:00 Generon Successfully Concludes First Phase III Clinical Trial of F-627 for Chemotherapy-induced Neutropenia
2018-01-24 18:24 Takeda Recognized as a Global 100 Most Sustainable Corporation for Third Consecutive Year
2018-01-24 16:34 European Commission Approves ADCETRIS® (brentuximab vedotin) for CD30-Positive Cutaneous T-Cell Lymphoma after One Prior Systemic Therapy– Providing an Innovative Treatment Option to Patients
2018-01-23 16:50 Octapharma: Low inhibitor rate with octanate® in previously untreated patients (PUPs) with severe haemophilia A
2018-01-23 16:10 New Study Investigates the Clinical Utility of ORi™, Masimo Oxygen Reserve Index™, in Obese Patients
2018-01-23 10:00 Ferring enters into worldwide OmniAb® platform license agreement with Ligand
2018-01-23 09:58 Harbour BioMed Completes Series A+ Round Financing to Accelerate the Development of Clinical Programs and Company Growth

Business Wire Weibo

Press Releases

Latest Releases